Everfront Biotech Holding Company Limited (EFB)

Everfront Biotech Holding Company will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

EFB Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	0	-	0.08
Gross Profit	0	-	0.08
Selling, General & Admin	-	1.68	0.73
Research & Development	-	0.71	1.06
Operating Expenses	-	2.39	1.78
Operating Income	-2.19	-2.39	-1.7
Interest Expense / Income	-0.01	-0.01	-0
Other Expense / Income	-0.05	-0.08	-0.21
Pretax Income	-2.13	-2.29	-1.49
Net Income	-2.13	-2.29	-1.49
Net Income Common	-2.13	-2.29	-1.49
Free Cash Flow	-1.87	-2.31	-1.92
Gross Margin	-	-	100.00%
Operating Margin	-	-	-2132.44%
Profit Margin	-	-	-1870.30%
Free Cash Flow Margin	-	-	-2407.77%
EBITDA	-2.1	-2.26	-1.46
EBITDA Margin	-	-	-1821.73%
Depreciation & Amortization	0.04	0.04	0.04
EBIT	-2.15	-2.3	-1.49
EBIT Margin	-	-	-1870.49%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).